Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares Repurchased
Ratios

Neurocrine Biosciences (NBIX) Shares Repurchased (2024 - 2025)

Neurocrine Biosciences' Shares Repurchased history spans 2 years, with the latest figure at $17.7 million for Q2 2025.

  • For Q2 2025, Shares Repurchased changed N/A year-over-year to $17.7 million; the TTM value through Dec 2025 reached $167.7 million, down 44.1%, while the annual FY2025 figure was $167.7 million, 44.1% down from the prior year.
  • Shares Repurchased reached $17.7 million in Q2 2025 per NBIX's latest filing, down from $150.0 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $300.0 million in Q4 2024 to a low of $17.7 million in Q2 2025.